novartis hits acquisition trail
swiss drugmaker novartis announced euros purchases sandoz unit biggest generic drug producer
novartis month forecast record sales bought germany hexal acquired hexal affiliate eon labs offered buy remaining shares novartis cost savings acquisitions novartis shares rose swiss francs trading
deal novartis sandoz business overtake israel teva pharmaceuticals biggest maker generics based figures newly merged producer sales company estimated novartis merge departments adding job cuts
strong growth outlook sandoz create jobs expected partially compensate reductions force firm statement generic drugs chemically identical expensive branded rivals producers sandoz copy branded products patent protection expires sell cheaply pay development cost
generic drugmakers worldwide analysts predicted consolidation market call fragmented analysts initially convinced deal expensive acquisition birgit kuhlhoff sal oppenheim investment bank told reuters strange acquisitions markets suffered price pressure
